OPTIFLOX 0.3% price in UAE

Overview

Welcome to Dwaey, specifically on OPTIFLOX 0.3% Eye Drops (Solution) page.
This medicine contains an important and useful components, as it consists of Ofloxacin.
OPTIFLOX 0.3% is available in the market in concentration 3mg/ml and in the form of Eye Drops (Solution).

JAMJOOM PHARMACEUTICALS COMPANY LTD. is the producer of OPTIFLOX 0.3% and it is imported from SAUDI ARABIA, The most popular alternatives of OPTIFLOX 0.3% are listed downward .

Mode Of Action

Ofloxacin is a fluoroquinolone which inhibits bacterial topoisomerase IV and DNA gyrase enzymes required for DNA replication, transcription, repair and recombination. It has activity against a wide range of gram-negative and gram-positive microorganisms.

Indication

Leprosy
chronic bronchitis; Community-acquired pneumonia; Uncomplicated skin infections
anthrax
Legionnaire's disease
Nongonococcal cervicitis; Urethritis
Uncomplicated cystitis
Complicated UTI
Traveller's diarrhea
bacterial prostatis
Typhoid fever
Skin and soft tissue infections
Uncomplicated gonorrhea
Pelvic inflammatory disease
Lower respiratory tract infections
Septicaemia

Precaution

Epilepsy or other predisposition to seizures; known or suspected CNS disorders; renal, hepatic impairment; myasthaenia gravis; superinfection; children <18 yr; exposure to strong sunlight and UV light; ensure adequate hydration; elderly. Lactation: excreted in breast milk, discontinue drug or do not nurse

Side Effects

1-10% Nausea (3-10%)
Headache (1-9%)
Insomnia (3-7%)
Dizziness (1-5%)
Vaginitis (1-5%)
Diarrhea (1-4%)
Vomiting (1-4%)
Appetite decreased (1-3%)
Abdominal cramps (1-3%)
Abnormal taste (1-3%)
Chest pain (1-3%)
External genital pruritis in women (1-3%)
Fatigue (1-3%)
Flatulence (1-3%)
GI distress (1-3%)
Nervousness (1-3%)
Pharyngitis (1-3%)
Pyrexia (1-3%)
Rash/pruritis (1-3%)
Sleep disorders (1-3%)
Visual disturbances (1-3%)
Xerostomia (1-3%) <1% Prolonged QT interval
Torsades de pointes
Syncope
Vasculitis
Edema
HTN
Palpitations
Vasodilation
Stevens-Johnson syndrome
Toxic epidermal necrolysis
Agranulocytosis
Aplastic anemia
Pancytopenia
Thrombocytopenia
Thrombocytopenic purpura
Acute hepatitis
Hepatic failure
Hepatic necrosiImmune hypersensitivity reaction
Rupture of tendon
Tendinitis
Peripheral neuropathy
Seizure
Acute renal failure
Interstitial nephritis
Renal impairment
Tourette's syndrome
Decrease hearing acuity
Tinnitus Potentially Fatal: Anaphylaxis; rarely seizures.

Contra indication

Hypersensitivity to quinolones; pregnancy and lactation; prolongation of the QT interval; uncorrected hypokalaemia.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Concomitant use of class IA (e.g. quinidine, procainamide) or class III (e.g. amiodarone, sotalol) antiarrhythmic agents may increase risk of QT interval prolongation. Decreased serum and urine concentrations w/ antacids containing Mg, Al or Ca. Additive antibacterial activity w/ aminoglycosides (e.g. amikacin, tobramycin). Corticosteroids may increase risk of severe tendon disorders. Increased risk of CNS stimulation (e.g. seizures) w/ NSAIDs. Higher and prolonged serum theophylline concentrations and increased risk of theophylline-related adverse effects.